Publications by authors named "Prejesh A Philips"
Article Synopsis
- The study investigates how to better manage exocrine pancreatic insufficiency (EPI) in pancreatic adenocarcinoma patients through treatments like oral pancreatic enzyme replacement therapy (PERT) and immobilized lipase cartridges (RELiZORB) during a specific time frame at Louisville Medical Center.
- EPI symptoms were prevalent in 80% of the 35 patients studied, with many using jejunostomy tubes and enzyme cartridges; those without tubes relied on PERT, both approaches significantly improved patient quality of life.
- The findings emphasize the importance of early EPI management to enhance patient care, facilitate a return to cancer treatment post-surgery, and improve overall quality of life for those undergoing pancreatic
Introduction: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is an effective, aggressive approach to treating intraperitoneal carcinomatosis. This study aimed to test the efficacy/safety of an enhanced recovery (ERAS) program after CRS-HIPEC surgery.
Methods: Review of an IRB-approved prospectively maintained HIPEC database from 2003 to 2019.
Introduction: This study compares radioembolization ((90)Y) versus doxorubicin drug eluting beads (DEBDOX) in the treatment of unresectable hepatocellular carcinoma with portal vein thrombosis.
Methods: Using our prospectively maintained, multi-center, non-controlled intra-arterial therapy registry, we identified 28 consecutive patients with hepatocellular carcinoma (HCC) and portal vein thrombosis (PVT) treated with DEBDOX and 20 with (90)Y. Follow-up protocol consisted of a 3-phase CT scan of the liver within 3 months post-treatment.